Skip to main content

Table 1 Pathogen-specific antibody levels in IVIG preparations

From: Antibody levels to tetanus, diphtheria, measles and varicella in patients with primary immunodeficiency undergoing intravenous immunoglobulin therapy: a prospective study

IVIG

Mean IU/mL

SD

Number of lots

Tetanus

19,92

10,19

38

Immunoglobulin®

20,04

1,60

2

Endobulin®

9,25

1,45

3

Flebogamma®

26,02

10,64

6

Octagam®

18,99

7,91

16

Tegeline®

18,64

13,68

9

Vigam®

30,58

3,70

2

Diphtheria

10,97

9,58

38

Immunoglobulin®

12,87

6,97

2

Endobulin®

7,82

5,29

3

Flebogamma®

19,86

19,35

6

Octagam®

10,05

6,48

16

Tegeline®

7,75

4,11

9

Vigam®

8,98

5,41

2

Measles

28,53

18,53

38

Immunoglobulin®

43,15

41,56

2

Endobulin®

9,65

0,53

3

Flebogamma®

35,04

12,73

6

Octagam®

23,04

16,10

16

Tegeline®

39,06

18,76

9

Vigam®

19,04

6,98

2

Varicella

21,75

12,19

38

Immunoglobulin®

19,47

10,87

2

Endobulin®

11,06

7,88

3

Flebogamma®

32,26

11,30

6

Octagam®

21,60

13,28

16

Tegeline®

20,90

10,12

9

Vigam®

13,62

0,42

2

  1. The bold data represent the mean for all of the 38 different lots.